ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266046; 2) Community: the network communities that were significantly associated with the response to NSC 266046; 3) Molecule: the relationships between components within communities and NSC 266046; 4) MDR: the compounds that were significantly associated with the NSC 266046.

NSC Compound Enrichment Correlation
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0135714101922724 0.37165862
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.0135714101922724 0.45884181
NSC 255105 GELDANAMYCIN ANALOG 0.0135714101922724 0.33826078
NSC 26273 6-Benzylthioinosine 0.0135714101922724 0.39546071
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0135714101922724 0.39302792
NSC 294526 Null 0.0135714101922724 0.3694351
NSC 316158 Null 0.0135714101922724 0.30506183
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0135714101922724 0.40948578
NSC 363812 Tetraplatin 0.0135714101922724 0.72593651
NSC 623599 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride 0.0135714101922724 0.32601476
Total:138  Current:58    [First] [Prev] [Next] [Last]